Protéine recombinante And NotA. M. Walmsley

List of bibliographic references

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
000C12	Anne Casset [Autriche] ; Adriano Mari [Italie] ; Ashok Purohit [France] ; Yvonne Resch [Autriche] ; Margit Weghofer [Autriche] ; Rosetta Ferrara [Italie] ; Wayne R. Thomas [Australie] ; Claudia Alessandri [Italie] ; Kuan-Wei Chen [Autriche] ; Frederic De Blay [France] ; Rudolf Valenta [Autriche] ; Susanne Vrtala [Autriche]	Varying Allergen Composition and Content Affects the in vivo Allergenic Activity of Commercial Dermatophagoides pteronyssinus Extracts
001B75	Ruth Ladenstein [Australie, Autriche, Italie, France, Royaume-Uni, Israël, Allemagne] ; Ulrike Pötschger ; Dimitris Siabalis ; Alberto Garaventa ; Christophe Bergeron ; Ian J. Lewis ; Jerry Stein ; Janice Kohler ; Peter J. Shaw ; Wolfgang Holter ; Vito Pistoia ; Jean Michon	Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion
002003	Peter L. Turecek [Autriche] ; Gerald Schrenk [Autriche] ; Hanspeter Rottensteiner [Autriche] ; Katalin Varadi [Autriche] ; Edouard Bevers [Pays-Bas] ; Peter Lenting [France] ; Nicola Ilk [Autriche] ; Uwe B. Sleytr [Autriche] ; Hartmut J. Ehrlich [Autriche] ; Hans Peter Schwarz [Autriche]	Structure and Function of a Recombinant von Willebrand Factor Drug Candidate
002434	Paul Harmatz [États-Unis] ; Zi-Fan Yu [États-Unis] ; Roberto Giugliani [Brésil] ; Ida Vanessa D. Schwartz [Brésil] ; Nathalie Guffon [France] ; Elisa Leao Teles [Portugal] ; M. Clara Sa Miranda [Portugal] ; J. Edmond Wraith [Royaume-Uni] ; Michael Beck [Allemagne] ; Laila Arash [Allemagne] ; Maurizio Scarpa [Italie] ; David Ketteridge [Australie] ; John J. Hopwood ; Barbara Plecko ; Robert Steiner ; Chester B. Whitley ; Paige Kaplan ; Stuart J. Swiedler ; Karen Hardy ; Kenneth I. Berger ; Celeste Decker	Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase
002736	G. S. Conway [Royaume-Uni] ; M. Szarras-Czapnik [Pologne] ; K. Racz [Hongrie] ; A. Keller [Allemagne] ; P. Chanson [France] ; M. Tauber [France] ; M. Zacharin [Australie]	Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency
002890	Markus Luster [Allemagne] ; Daria Handkiewicz-Junak [Pologne] ; Armando Grossi [Italie] ; Margaret Zacharin [Australie] ; David Taïeb [France] ; Ofelia Cruz [Espagne] ; Anne Hitzel [France] ; Juan Antonio Vallejo Casas [Espagne] ; Uwe M Der [Allemagne] ; Massimo E. Dottorini [Italie]	Recombinant Thyrotropin Use in Children and Adolescents with Differentiated Thyroid Cancer: A Multicenter Retrospective Study
002D90	M. Weghofer [Autriche] ; W. R. Thomas [Australie] ; M. Kronqvist [Suède] ; A. Mari [Italie] ; A. Purohit [France] ; G. Pauli [France] ; F. Horak [Autriche] ; H. Grönlund [Suède] ; M. Van Hage [Suède] ; R. Valenta [Autriche] ; S. Vrtala [Autriche]	Variability of IgE reactivity profiles among European mite allergic patients
004855	M. W. Lightowlers [Australie]	Vaccination for the prevention of cysticercosis
004E41	K. Geissler [Autriche] ; J. A. Liu Yin [Royaume-Uni] ; A. Ganser [Allemagne] ; M. A. Sanz [Espagne] ; J. Szer [Australie] ; A. Raghavachar [Allemagne] ; D. Hoelzer [Allemagne] ; C. Martinez [Espagne] ; K. Taylor [Australie] ; L. Kanz [Allemagne] ; L. B. To [Australie] ; E. Archimbaud [France]	Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia: a randomized, placebo-controlled, double-blind safety and efficacy study
005632	J. Miller [Australie] ; D. Becker [Australie] ; B. Dugdale [Australie] ; R. Harding [Australie] ; J. Aaskov [Australie] ; I. Frazer [Australie] ; J. Dale [Australie]	Towards the development of edible vaccines for human papillomavirus in bananas
005832	C. S. Bawden [Australie] ; C. J. Mclaughlan [Australie] ; S. K. Walker [Australie] ; P. A. Speck [Australie] ; B. C. Powell [Australie] ; M. J. Huson [Australie] ; L. N. Jones [Australie] ; G. E. Rogers [Australie]	Improvement of wool quality by transgenesis
005D95	V. Carreno [Espagne] ; S. Zeuzem [Allemagne] ; U. Hopf [Allemagne] ; P. Marcellin [France] ; W. G. E. Cooksley [Australie] ; J. Fevery [Belgique] ; M. Diago [Espagne] ; R. Reddy [États-Unis] ; M. Peters [États-Unis] ; K. Rittweger [États-Unis] ; A. Rakhit [États-Unis] ; M. Pardo [Espagne]	A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
006505	J. A. Triccas [France] ; T. Parish [Royaume-Uni] ; W. J. Britton [Australie] ; B. Gicquel [France]	An inducible expression system permitting the efficient purification of a recombinant antigen from Mycobacterium smegmatis

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024